Emergence of cytomegalovirus disease in patients receiving temozolomide : report of two cases and literature review

Temozolomide chemotherapy has become part of the therapy used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. Temozolomide frequently produces profound lymphopenia. We report 2 cases of cytomegalovirus disease that occurred in patients receiving temozolomide therapy and review 4 additional cases reported in the literature. Narrow monitoring with cytomegalovirus antigenemia assay should be considered for recommendation.

Medienart:

E-Artikel

Erscheinungsjahr:

2010

Erschienen:

2010

Enthalten in:

Zur Gesamtaufnahme - volume:50

Enthalten in:

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 50(2010), 12 vom: 15. Juni, Seite e73-6

Sprache:

Englisch

Beteiligte Personen:

Meije, Yolanda [VerfasserIn]
Lizasoain, Manuel [VerfasserIn]
García-Reyne, Ana [VerfasserIn]
Martínez, Pilar [VerfasserIn]
Rodríguez, Virginia [VerfasserIn]
López-Medrano, Francisco [VerfasserIn]
Juan, Rafael San [VerfasserIn]
Lalueza, Antonio [VerfasserIn]
Aguado, José María [VerfasserIn]

Links:

Volltext

Themen:

7GR28W0FJI
Antineoplastic Agents, Alkylating
Case Reports
Dacarbazine
Journal Article
Research Support, Non-U.S. Gov't
Review
Temozolomide
YF1K15M17Y

Anmerkungen:

Date Completed 27.07.2010

Date Revised 01.12.2018

published: Print

Citation Status MEDLINE

doi:

10.1086/653011

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM197951562